Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$17,500.00

Does impaired novelty seeking underlie apathy in amyotrophic lateral sclerosis?

EF 2009-10

Résumé
Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by progressive paralysis and death within 3 to 5 years of diagnosis. While traditionally considered a purely motor disease, cognitive dysfunction is present in a large minority of patients. Cognitive impairment is associated with co-existing frontotemporal lobar degeneration, of which apathy is the most common symptom. While impaired novelty seeking - characterized by a decreased preference for novel over familiar stimuli - is correlated with both frontal lobe dysfunction and apathy, no studies have examined whether apathetic behaviour in patients with ALS is associated with similar decreases in novelty seeking. This study investigates whether apathy in ALS (measured by the Frontal Systems Behaviour Scale, or FrSBe) is correlated with decreased viewing duration of novel patterns versus repetitive background symbols on a novelty seeking test, and whether such a decrease in viewing duration is accompanied by lower blood flow to the frontal lobes compared with controls during functional magnetic resonance imaging (fMRI). This is the first study to examine the neuroanatomical and cognitive correlates of apathy using high-field fMRI in patients with ALS. This investigation may lead to: a better understanding of the biological basis of behavioural impairment in ALS (which is a precondition for developing successful treatments); increased attention to and treatment of the psychological symptoms of ALS; and the eventual introduction of fMRI as an assistive tool in diagnosing cognitive impairment in patients with ALS.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
200308
Name
Osborne Richard
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Does impaired novelty seeking underlie apathy in amyotrophic lateral sclerosis?
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Amyotrophic Lateral Sclerosis; Apathy; Cognitive Dysfunction; Disinhibition; Functional Magnetic Resonance Imaging; Lower Motor Neuron Disease; Novelty Seeking; Upper Motor Neuron Disease
Abstract
Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by progressive paralysis and death within 3 to 5 years of diagnosis. While traditionally considered a purely motor disease, cognitive dysfunction is present in a large minority of patients. Cognitive impairment is associated with co-existing frontotemporal lobar degeneration, of which apathy is the most common symptom. While impaired novelty seeking - characterized by a decreased preference for novel over familiar stimuli - is correlated with both frontal lobe dysfunction and apathy, no studies have examined whether apathetic behaviour in patients with ALS is associated with similar decreases in novelty seeking. This study investigates whether apathy in ALS (measured by the Frontal Systems Behaviour Scale, or FrSBe) is correlated with decreased viewing duration of novel patterns versus repetitive background symbols on a novelty seeking test, and whether such a decrease in viewing duration is accompanied by lower blood flow to the frontal lobes compared with controls during functional magnetic resonance imaging (fMRI). This is the first study to examine the neuroanatomical and cognitive correlates of apathy using high-field fMRI in patients with ALS. This investigation may lead to: a better understanding of the biological basis of behavioural impairment in ALS (which is a precondition for developing successful treatments); increased attention to and treatment of the psychological symptoms of ALS; and the eventual introduction of fMRI as an assistive tool in diagnosing cognitive impairment in patients with ALS.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Osborne, Richard
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~